Effect of different doses and time‑courses of corticosteroid treatment in patients with acute respiratory distress syndrome: A meta‑analysis

Sun,Shuangshuang; Liu,Dadong; Zhang,Hao; Zhang,Xiuwei; Wan,Bing

doi:10.3892/etm.2019.8167

Effect of different doses and time‑courses of corticosteroid treatment in patients with acute respiratory distress syndrome: A meta‑analysis

Authors:
- Shuangshuang Sun
- Dadong Liu
- Hao Zhang
- Xiuwei Zhang
- Bing Wan
View Affiliations

Affiliations: Department of Respiratory and Critical Care Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu 210002, P.R. China, ICU, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, P.R. China, Emergency Department, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, P.R. China
Published online on: November 4, 2019 https://doi.org/10.3892/etm.2019.8167
Pages: 4637-4644
Copyright: © Sun et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

While previous trials have indicated that the use of corticosteroids for patients with acute respiratory distress syndrome (ARDS) is effective, the dosage and time‑course for the use of corticosteroids remain a subject of controversy. The present study aimed to address and resolve these problems. PubMed, Embase and the Cochrane Library databases were searched from inception to March 2017 for randomized controlled trials (RCTs), which included patients with ARDS using corticosteroids. Related data were extracted independently by two investigators. The Mantel‑Haenszel method was used with random‑effects modeling to calculate the pooled odds ratio (OR) and 95% confidence interval (CI) for the mortality of patients with ARDS, and the risk of new infection arising from the use of glucocorticoids. The inverse variance method was used to calculate the mean difference (MD) and 95% CI for the duration of mechanical‑free ventilation and the ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO2/FIO2 ratio). The use of low‑dose corticosteroids significantly reduced the mortality rate of patients with ARDS (OR: 0.43; 95% CI: 0.24‑0.79; P=0.006) while the use of high‑dose corticosteroids provided no significant benefit to reducing the mortality rate (OR: 1.33; 95% CI: 0.86‑2.04; P=0.20). The present study identified that glucocorticoids reduced the mortality rate of patients during the early stages of ARDS (OR: 0.61; 95% CI: 0.43‑0.86; P=0.005). Glucocorticoids significantly reduced the duration of mechanical ventilation (MD: 3.08; 95% CI: 1.49‑4.68; P<0.05) and significantly improved the PaO2/FiO2 ratio (MD: 66.39; 95% CI: 57.79‑74.98; P<0.05). The use of corticosteroids did not significantly increase the rate of infectious complications (OR: 0.60; 95% CI: 0.32‑1.12; P>0.05). The use of low‑dose corticosteroids may significantly reduce the mortality rate, particularly in the early stages of ARD, shorten the duration of mechanical ventilation and improve the PaO2/FiO2 ratio without increasing the risk of a new infection.

View Figures

View References

1	Ware LB and Matthay MA: The acute respiratory distress syndrome. N Engl J Med. 342:1334–1349. 2000. View Article : Google Scholar : PubMed/NCBI
2	Meduri GU, Annane D, Chrousos GP, Marik PE and Sinclair SE: Activation and regulation of systemic inflammation in ARDS: Rationale for prolonged glucocorticoid therapy. Chest. 136:1631–1643. 2009. View Article : Google Scholar : PubMed/NCBI
3	Meduri GU and Eltorky MA: Understanding ARDS-associated fibroproliferation. Intensive Care Med. 41:517–520. 2015. View Article : Google Scholar : PubMed/NCBI
4	Roch A, Guervilly C and Papazian L: Fluid management in acute lung injury and ards. Ann Intensive Care. 1:162011. View Article : Google Scholar : PubMed/NCBI
5	Lamberts SW, Bruining HA and de Jong FH: Corticosteroid therapy in severe illness. N Engl J Med. 337:1285–1292. 1997. View Article : Google Scholar : PubMed/NCBI
6	Chirousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 332:1351–1362. 1995. View Article : Google Scholar : PubMed/NCBI
7	Udelsman R, Ramp J, Gallucci WT, Gordon A, Lipford E, Norton JA, Loriaux DL and Chrousos GP: Adaptation during surgical stress. A reevaluation of the role of glucocorticoids. J Clin Invest. 77:1377–1381. 1986. View Article : Google Scholar : PubMed/NCBI
8	MacLaren R and Jung R: Stress-dose corticosteroid therapy for sepsis and acute lung injury or acute respiratory distress syndrome in critically ill patients. Pharmacotherapy. 22:1140–1156. 2002. View Article : Google Scholar : PubMed/NCBI
9	Newton R: Molecular mechanisms of glucocorticoid action: What is important? Thorax. 55:603–613. 2000. View Article : Google Scholar : PubMed/NCBI
10	Annane D, Sébille V and Bellissant E; Ger-Inf-05 Study Group, : Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med. 34:22–30. 2006. View Article : Google Scholar : PubMed/NCBI
11	Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, Della Porta R, Giorgio C, Blasi F, Umberger R and Meduri GU: Hydrocortisone infusion for severe community-acquired pneumonia: A preliminary randomized study. Am J Respir Crit Care Med. 171:242–248. 2005. View Article : Google Scholar : PubMed/NCBI
12	Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M and Umberger R: Methylprednisolone infusion in early severe ARDS: Results of a randomized controlled trial. Chest. 131:954–963. 2007. View Article : Google Scholar : PubMed/NCBI
13	Foster JR; Steroids for early acute respiratory distress syndrome: Critical appraisal of, ; Meduri GU, Golden E, Freire AX, et al: Methylprednisolone infusion in early severe ARDS: Results of a randomized controlled trial. Chest. 2007.131:954–963, Pediatr Crit Care Med 11: 404–407. 2010. View Article : Google Scholar : PubMed/NCBI
14	Lamontagne F, Briel M, Guyatt GH, Cook DJ, Bhatnagar N and Meade M: Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome and severe pneumonia: A meta-analysis of randomized controlled trials. J Crit Care. 25:420–435. 2010. View Article : Google Scholar : PubMed/NCBI
15	Hoogwerf B and Danese RD: Drug selection and the management of corticosteroid-related diabetes mellitus. Rheum Dis Clin North Am. 25:489–505. 1999. View Article : Google Scholar : PubMed/NCBI
16	McDonough AK, Curtis JR and Saag KG: The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol. 20:131–137. 2008. View Article : Google Scholar : PubMed/NCBI
17	Weigelt JA, Norcross JF, Borman KR and Snyder WH III: Early steroid therapy for respiratory failure. Arch Surg. 120:536–540. 1985. View Article : Google Scholar : PubMed/NCBI
18	Agarwal R, Nath A, Aggarwal A and Gupta D: Do glucocorticoids decrease mortality in acute respiratory distress syndrome? A meta-analysis. Respirology. 12:585–590. 2007. View Article : Google Scholar : PubMed/NCBI
19	Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L and Slutsky AS: Acute respiratory distress syndrome: The berlin definition. JAMA. 307:2526–2533. 2012.PubMed/NCBI
20	Savović J, Weeks L, Sterne JA, Turner L, Altman DG, Moher D and Higgins JP: Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: Focus groups, online survey, proposed recommendations and their implementation. Syst Rev. 3:372014. View Article : Google Scholar : PubMed/NCBI
21	Zeiss EE and Hanley JA: Mantel-Haenszel techniques and logistic regression: Always examine one's data first and don't overlook the simpler techniques. Paediatr Perinat Epidemiol. 6:311–315. 1992. View Article : Google Scholar : PubMed/NCBI
22	Higgins JP and Green S: Cochrane handbook for systematic reviews of interventions. Version 5.2.0The Cochrane Collaboration. 2017
23	Ning G, et al: The guidelines for clinical usage of glucocorticoid. Chin J Endocrinol Metab. 28:2012.
24	Lee HS, Lee JM, Kim MS, Kim HY, Hwangbo B and Zo JI: Low-dose steroid therapy at an early phase of postoperative acute respiratory distress syndrome. Ann Thorac Surg. 79:405–410. 2005. View Article : Google Scholar : PubMed/NCBI
25	Liu L, Li J, Huang YZ, Liu SQ, Yang CS, Guo FM, Qiu HB and Yang Y: The effect of stress dose glucocorticoid on patients with acute respiratory distress syndrome combined with critical illness-related corticosteroid insufficiency. Zhonghua Nei Ke Za Zhi. 51:599–603. 2012.(In Chinese). PubMed/NCBI
26	Seam N, Meduri GU, Wang H, Nylen ES, Sun J, Schultz MJ, Tropea M and Suffredini AF: Effects of methylprednisolone infusion on markers of inflammation, coagulation, and angiogenesis in early acute respiratory distress syndrome. Crit Care Med. 40:495–501. 2012. View Article : Google Scholar : PubMed/NCBI
27	Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT and Ancukiewicz M: National heart, lung, and blood institute acute respiratory distress syndrome(ARDS) clinical trials network: Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 354:1671–1684. 2006. View Article : Google Scholar : PubMed/NCBI
28	Wan MH, Li J, Gong HL, Xue P, Zhu L, Chen GY, Xia Q and Wen-Fu T: Clinical observation on the effect of dexamethasone and Chinese herbal decoction for purgation in severe acute pancreatitis patients. Chin J Integr Med. 17:141–145. 2011. View Article : Google Scholar : PubMed/NCBI
29	Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ, Kariman K, Higgins S, Bradley R and Metz CA: High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 317:1565–1570. 1987. View Article : Google Scholar : PubMed/NCBI
30	Thompson BT: Glucocorticoids and acute lung injury. Crit Care Med. 31 (4 Suppl):S253–S257. 2003. View Article : Google Scholar : PubMed/NCBI
31	Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA and Balk RA: Sepsis syndrome: A valid clinical entity. Methylprednisolone severe sepsis study group. Crit Care Med. 17:389–393. 1989. View Article : Google Scholar : PubMed/NCBI
32	Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA and Murray JF: Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis. 138:62–68. 1988. View Article : Google Scholar : PubMed/NCBI
33	Ruan SY, Lin HH, Huang CT, Kuo PH, Wu HD and Yu CJ: Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: A systematic review and meta-analysis. Crit Care. 18:R632014. View Article : Google Scholar : PubMed/NCBI